Patient | Sex | Age (years) | Diagnosis | Weight (kg) | APACHE II | The cause of AKI | The value of Cre on admission to ICU (mg/dl) | Duration of CHDF (days) |
---|---|---|---|---|---|---|---|---|
1 | Male | 75 | Ruptured AAA | 70.7 | 31 | Hemorrhagic shock | 1.32 | 66 |
2 | Male | 59 | OHCA | 88.9 | 42 | PCAS | 0.98 | 5 |
3 | Male | 46 | Congenital heart disease | 50.0 | 21 | Major cardiac operation | 0.69 | 45 |
4 | Male | 58 | ML | 58.3 | 41 | Drug induced | 2.04 | 38 |
Mean ± SE | 59.5 ± 6.0 | - | 70.0 ± 8.5 | 33.8 ± 4.9 | - | 1.25 + 0.29 | 38.5 + 12.7 | |
BUN (mmol/l) | 24 h CL cre (ml/min) | Q D (l/h) | Q F (l/h) | Predictive CL total (l/h) | Calculated optimal dose of LVFX (mg) | |||
42 | 3.4 | 1.0 | 2.0 | 4.0 | 200 | |||
43 | 0.9 | 1.0 | 2.0 | 4.0 | 200 | |||
40 | - | 1.0 | 2.0 | - | - | |||
32 | 3.4 | 0.5 | 1.5 | 2.9 | 145 | |||
39.3 ± 5.0 | 2.6 ± 0.8 | 0.86 + 0.13 | 1.88 + 0.13 | 3.6 ± 0.4 | 182 + 18.3 |